NFE2L2 and breast cancer: Studies have also demonstrated that luteolin could suppress the sphere formation of breast cancer stem cells (CSCs) and further enhance the chemosensitivity of anticancer drug taxol through downregulating Nrf2 expression via inhibiting the antioxidant genes HO-1 and Cripto-1, which have been known to contribute to CSC features.